Safety and efficacy of adalimumab (D2E7) in Crohn's disease patients with an attenuated response to infliximab - Commentary

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Number of pages1
JournalDiseases of the Colon and Rectum
Volume49
Issue number11
DOIs
StatePublished - Nov 1 2006
Externally publishedYes

ASJC Scopus subject areas

  • Gastroenterology

Cite this